UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014533
Receipt number R000016885
Scientific Title Study on effects of a plant-derived protein containing food product on postprandial hyperglycemia
Date of disclosure of the study information 2014/07/15
Last modified on 2019/07/25 13:29:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on effects of a plant-derived protein containing food product on postprandial hyperglycemia

Acronym

Study on effects of a plant-derived protein containing food product on postprandial hyperglycemia

Scientific Title

Study on effects of a plant-derived protein containing food product on postprandial hyperglycemia

Scientific Title:Acronym

Study on effects of a plant-derived protein containing food product on postprandial hyperglycemia

Region

Japan


Condition

Condition

Postprandial hyperglycemia

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effects of a food product on postprandial hyperglycemia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

postprandial blood glucose

Key secondary outcomes

Insulin, TG, GIP, GLP-1, ghrelin, appetite (satiety)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

placebo food

Interventions/Control_2

active food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

1, Fasting blood glucose > 94, and <126 mg/dL
2, HbA1c (NGSP) > 5.1, and <6.5
3, Aged between 30 and 59
4, BMI >22.9 and <30 kg/m2
5, Person who can accept to be accessed their medical records and agree with the study protocol followed by a prior explanation
6, Person who provides informed consent by a document
7, Depends on the screening condition of above 1 to 3 criteria, person who does not meet the criteria can be screened in case that the physican in charge, the client and the CRO reach to agreement of it.

Key exclusion criteria

1, Person who is difficult to participate the study due to dysfunctions of liver, kidney, heart, respiration, endocrine secretion, metabolism, nervous system, consciousness or diabetes, or the other dysfunctions
2, Person who was given surgery for a disease or an injury 2 months prior to the study
3, Person who was given gastrectomy and/or bypass of part of the intestine
4, Person who takes medication for glucose or fat metabolism, or hypertension
5, Person who habitually consumes the foods for specific health use (FOSHU) and/or dietary supplements (capsules) (except for person who can stop to consume them right after informed consent)
6, Person who is or had been given treatment for allergies to test food ingredients
7, Person who has been ill due to blood collecting
8, Person who donated 200mL or more of blood within a month prior to the study
9, Person who skip breakfast habitually
10, Heavy smoker or person who cannot stop

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Shinichiro
Middle name
Last name Saito

Organization

Kao Corporation

Division name

Health Care Food Research Labs.

Zip code

131-8501

Address

2-1-3 Bunka Sumida-ku Tokyo

TEL

03-5630-7456

Email

saito.shinichiro@kao.co.jp


Public contact

Name of contact person

1st name Toshiyasu
Middle name
Last name Tamura

Organization

TES Holdings Co. Ltd

Division name

Sales department for tissue engineering and clinical research

Zip code

103-0027

Address

Tokyo Univ 6F, 7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-6801-8480

Homepage URL


Email

t.tamura@tes-h.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethical Committee of the Oriental Ueno Kenshin Center

Address

1-20-11 Ueno, Taito-ku, Tokyo

Tel

03-5816-0711

Email

ueno-center@oriental-gr.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人 相生会 墨田病院


Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 15 Day


Related information

URL releasing protocol

Unpublished due to the protocol including the intellectual property rights

Publication of results

Published


Result

URL related to results and publications

https://www.mdpi.com/2072-6643/11/1/187

Number of participants that the trial has enrolled

20

Results

There was a significantly difference in the primary outcome between the groups

Results date posted

2019 Year 07 Month 25 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

healthy men

Participant flow

22 were screened and 20 were analyzed

Adverse events

No adverse events occurred associated with consumption of the test diets

Outcome measures

Postprandial blood glucose

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 07 Month 15 Day

Date of IRB

2014 Year 07 Month 15 Day

Anticipated trial start date

2014 Year 07 Month 26 Day

Last follow-up date

2014 Year 08 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 07 Month 11 Day

Last modified on

2019 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016885


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name